References
- Mold C, Gewurz H, Du Clos TW. Regulation of complement activation by C-reactive protein. Immunopharmacol. 1999;42:23–30. doi:https://doi.org/10.1016/S0162-3109(99)00007-7
- Roumenina LT, Ruseva MM, Zlatarova A, et al. Interaction of C1q with IgG1, C-reactive protein and pentraxin 3: mutational studies using recombinant globular head modules of human C1q A, B, and C chains. Biochemistry. 2006;45(13):4093–4104.doi:https://doi.org/10.1021/bi052646f.
- Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9(APR). doi:https://doi.org/10.3389/fimmu.2018.00754.
- Coventry BJ, Ashdown ML, Quinn MA, Markovic SN, Yatomi-Clarke SL, Robinson AP. CRP identifies homeostatic immune oscillations in cancer patients: A potential treatment targeting tool? J Transl Med. 2009;7(1):102. doi:https://doi.org/10.1186/1479-5876-7-102.
- Kushner I, Jiang S, Zhang D et al. GL-A of the N, 1995 undefined. Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1? academia.edu. https://www.academia.edu/download/47542754/j.1749-6632.1995.tb32318.x20160726-1445-103s44b.pdf. Accessed May 16, 2020.
- Alende-Castro V, Medicine MA-S, 2019 Factors influencing erythrocyte sedimentation rate in adults: new evidence for an old test. ncbi.nlm.nih.gov. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6716712/. Accessed May 16, 2020.
- Patil P, Karia N, Jain S, brain BD-E and, 2013 undefined. Giant cell arteritis: a review. ncbi.nlm.nih.gov. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5432116/. Accessed May 16, 2020.
- Augstburger E, Héron E, Abanou A, et al. CH-JF, 2020 undefined. Acute ischemic optic nerve disease: pathophysiology, clinical features and management. Elsevier. https://www.sciencedirect.com/science/article/pii/S0181551219305315. Accessed May 16, 2020.
- Del Rincón I, Williams K, Stern MP, Freeman GL, O’Leary DH, Escalantel A. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum. 2003;48(7):1833–1840. doi:https://doi.org/10.1002/art.11078.
- Yayan J. Erythrocyte sedimentation rate as a marker for coronary heart disease. Vasc Health Risk Manag. 2012;8(1):219–223. doi:https://doi.org/10.2147/VHRM.S29284.
- Berliner S, Rogowski O, Aharonov S, et al. Erythrocyte adhesiveness/aggregation: A novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J. 2005;149(2):260–267.doi:https://doi.org/10.1016/j.ahj.2004.05.058.
- Rogowski O, Toker S, Shapira I, et al. Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol. 2005;95(1):152–155.doi:https://doi.org/10.1016/j.amjcard.2004.08.086.
- Schechner V, Shapira I, Berliner S, et al. Significant dominance of fibrinogen over immunoglobulins, C-reactive protein, cholesterol and triglycerides in maintaining increased red blood cell adhesiveness/aggregation in the peripheral venous blood: a model in hypercholesterolaemic patients. Eur J Clin Invest. 2003;33(11):955–961.doi:https://doi.org/10.1046/j.1365-2362.2003.01260.x.
- Zeltser D, Rogowski O, Berliner S, et al. Sex differences in the expression of haemorheological determinants in individuals with atherothrombotic risk factors and in apparently healthy people. Heart. 2004;90(3):277–281.doi:https://doi.org/10.1136/hrt.2003.014753.
- Zeltser D, Rogowski O, Mardi T, et al. Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive C-reactive protein. Atherosclerosis. 2004;176(2):297–301.doi:https://doi.org/10.1016/j.atherosclerosis.2004.04.015.
- Hayreh SS. Ischemic optic neuropathies - Where are we now? Graefe’s Arch Clin Exp Ophthalmol. 2013;251(8):1873–1884. doi:https://doi.org/10.1007/s00417-013-2399-z.
- Hayreh SS, Podhajsky PA, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria. Am J Ophthalmol. 1997;123(3):285–296. doi:https://doi.org/10.1016/S0002-9394(14)70123-0.
- Hayreh SS, Zimmerman B. Management of Giant Cell Arteritis. Ophthalmologica. 2003;217(4):239–259. doi:https://doi.org/10.1159/000070631.
- Arbel Y, Eros Y, Rogowski O, et al. Comparison of values of wide-range C-reactive protein to high-sensitivity C-reactive protein in patients undergoing coronary angiography. Am J Cardiol. 2007;99(11):1504–1506.doi:https://doi.org/10.1016/j.amjcard.2007.01.020.
- Arbel Y, Finkelstein A, Halkin A, et al. Neutrophil/lymphocyte ratio is related to the severity of coronary artery disease and clinical outcome in patients undergoing angiography. Atherosclerosis. 2012;225(2):456–460.doi:https://doi.org/10.1016/j.atherosclerosis.2012.09.009.
- Rogowski O, Shapira I, Shirom A, Melamed S, Toker S, Berliner S. Heart rate and microinflammation in men: A relevant atherothrombotic link. Heart. 2007;93(8):940–944. doi:https://doi.org/10.1136/hrt.2006.101949.
- Rogowski O, Shapira I, Steinvil A, Berliner S. Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Metabolism. 2009;58(5):661–667. doi:https://doi.org/10.1016/j.metabol.2009.01.005.
- Steinvil A, Shirom A, Melamed S, et al. ST-TA journal of, 2008 undefined. Relation of educational level to inflammation-sensitive biomarker level. Elsevier. https://www.sciencedirect.com/science/article/pii/S0002914908010217. Accessed January 17, 2020.
- Kerner W, Brückel J. Definition, classification and diagnosis of diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014;122(7):384–386. doi:https://doi.org/10.1055/s-0034-1366278.
- Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–1252.doi:https://doi.org/10.1161/01.HYP.0000107251.49515.c2.
- Rhee EJ, Kim HC, Kim JH, et al. 2018 Guidelines for the management of dyslipidemia. Korean J Intern Med. 2019;34(4):723–771.doi:https://doi.org/10.3904/kjim.2019.188.
- Libby P. Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013;368(21):2004–2013. doi:https://doi.org/10.1056/NEJMra1216063.
- Hayreh SS. Non-arteritic anterior ischemic optic neuropathy versus cerebral ischemic stroke. Graefe’s Arch Clin Exp Ophthalmol. 2012;250(9):1255–1260. doi:https://doi.org/10.1007/s00417-012-2026-4.
- Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263–271. doi:https://doi.org/10.1016/j.jacc.2013.02.092.
- Kesler A, Irge D, Rogowski O, et al. High-sensitivity C-reactive protein measurements in patients with non-arteritic anterior ischaemic optic neuropathy: A clue to the presence of a microinflammatory response. Acta Ophthalmol. 2009;87(2):216–221.doi:https://doi.org/10.1111/j.1755-3768.2008.01199.x.